Andrew Alliance announces $14m Series C investment by leading life sciences enterprises

– SWITZERLAND, Geneva – Andrew Alliance S.A., the robotics company that is improving repeatability with an innovative approach to liquid handling with conventional laboratory pipettes, today announced a $14 million investment by several of the leading life sciences enterprises, including Tecan Group, the Waters Corporation, Inpeco, Rancilio Cube, Sam Eletr Trust and Omega Funds.…

Sensome announces completion of €4.6m financing round led by Kurma Partners

– FRANCE, Palaiseau – Sensome, the company pioneering the connected medical device revolution with the world’s smallest sensor to identify biological tissues, announced today the successful completion of a new 4.6 million euro financing round to bring the Clotild smart stroke guidewire to market.…

Nimbus Therapeutics confirms investors’ strong and enthusiastic support with $65m new financing to fuel expansion and pipeline

– USA, MA – Nimbus Therapeutics, a privately held biotechnology company applying deep computational expertise throughout drug discovery and development, today announced that it has raised $65 million in new capital to accelerate the company’s pipeline progress and fuel its expansion into new high-value targets aimed at overlapping biological mechanisms in immunology, oncology and metabolic disease.…